
EUROPE: Adoption of the new EFSA guidance document for dermal absorption
25 June 2018
EUROPE: Updates of AIR 3 and AIR 4 working documents
23 July 2018Further to the publication in January of Regulation (EU) 2018/155 allocating the MS for the renewal of AIR5 active substances, the Commission has released a work programme:
- the decision of 06 June 2018 gives priority to the evaluation of active substances that may fail the approval criteria (= that meet the “cut-off” criteria) and of candidates for substitution, and groups the evaluation of active substances with similar properties
- the draft working document SANTE/2018/10048 provides an overview of indicative dates for application and dossier submission of 66 active substances. They are divided into 2 groups: no change in expiry date, a.s. to be potentially extended.
To download:
SANTE-2018-10048–rev 1 (June 2018): Draft working document establishing the fifth renewal programme
See also our previous article:
EUROPE: Allocation of MS for AIR4 and AIR5 active substances
Lynxee consulting’s team is at your disposal to answer your questions.
Contact us! https://lynxee.consulting/en/contact/30